DNA methylation of <em>SMPD3</em>-based diagnostic biomarkers of NASH and mild fibrosis

Na Wu; Mofan Feng; Siran Yue; Xinyu Shi; Nan Tang; Yalan Xiong; Jianying Wang; Lei Zhang; Hualing Song; Yi Shi; Guang He; Guang Ji; Baocheng Liu

doi:10.1016/j.gendis.2023.03.023

您当前的位置：

首页 >

文章列表页 >

DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis

Rapid Communications | 更新时间：2024-02-04

- DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis
- DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis
- Genes & Diseases 2024年1卷第1期页码：99-102
- 作者机构：
  
  1. Shanghai Innovation Center of Traditional Chinese Medicine Health Service, School of Public Health, Shanghai University of Traditional Chinese Medicine,Shanghai,China,201203
  2. Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University,Shanghai,China,200030
  3. Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University,Hong Kong SAR,China,999077
  4. Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine,Shanghai,China,200032
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.03.023
  中图分类号：
- 纸质出版日期：2024，
  
  网络出版日期：2024-1-1，
扫描看全文
DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis[J]. Genes & Diseases, 2024,1(1):99-102.

Na Wu, Mofan Feng, Siran Yue, et al. DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis[J]. Genes & Diseases, 2024,1(1):99-102.
DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis[J]. Genes & Diseases, 2024,1(1):99-102. DOI： 10.1016/j.gendis.2023.03.023.

Na Wu, Mofan Feng, Siran Yue, et al. DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis[J]. Genes & Diseases, 2024,1(1):99-102. DOI： 10.1016/j.gendis.2023.03.023.

摘要

Abstract

关键词

Keywords

references

1 C.J. Pirola, T.F. Gianotti, A.L. Burgueño, et al.Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease Gut, 62 (9) (2013), pp. 1356-1363

2 Y. Shi, Z. Guo, X. Su, et al.DeepAntigen: a novel method for neoantigen prioritization via 3D genome and deep sparse learning Bioinformatics, 36 (19) (2020), pp. 4894-4901

3 J. Wang, J. Li, J. Gu, et al.Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma Oncol Lett, 10 (5) (2015), pp. 3073-3080

4 M. Kolak, J. Westerbacka, V.R. Velagapudi, et al.Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity Diabetes, 56 (8) (2007), pp. 1960-1968

5 P.S. Dulai, S. Singh, J. Patel, et al.Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis Hepatology, 65 (5) (2017), pp. 1557-1565

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据

DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis

DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis

DOI：10.1016/j.gendis.2023.03.023

摘要

Abstract

关键词

Keywords

references